scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2: a storm is raging.

Savannah F. Pedersen, +1 more
- 01 May 2020 - 
- Vol. 130, Iss: 5, pp 2202-2205
TLDR
Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design and the authors found that respiratory distress on admission is associated with unfavorable outcomes.
Abstract
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunological characteristics between moderate and severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.

read more

Citations
More filters
Journal ArticleDOI

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients

TL;DR: In this paper, the potential use of um-PEA as an adjuvant treatment in SARS-CoV-2 infection was discussed, where the Food and Drug Administration (FDA) authorized an ongoing clinical trial with ultramicronized (um)-PEA (PEA) as an add-on therapy in the treatment of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS)-CoV2 infection.
Journal ArticleDOI

Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients.

TL;DR: In this article, the PI3K/Akt/mTOR pathway was used to control anti-viral immune responses in COVID-19 patients, which can lead to both a dangerous cytokine storm and development of blood-borne factors that render severe thrombotic events more likely.
Journal ArticleDOI

Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features.

TL;DR: The risk prediction nomogram incorporating age, C-reactive protein, and D-dimer for early identification of severe COVID-19 patients showed favorable discrimination in both the primary and validation cohorts and was well calibrated.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Related Papers (5)